YJP-60107

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameYJP-60107
Drug Alias Namecaspase inhibitors (Yungjin/Korea Institute of Chemical Technology)YJP-60107YJP-60295
ClassificationSmall molecules
Mechanisms of ActionCaspase inhibitorsNeuroprotectants
TargetsCaspase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYungjin Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A